Rindi G, Wiedenmann B (2012) Neuroendocrine neoplasms of the gut and pancreas: new insights. Nat Rev Endocrinol 8(1):54–64

Google Scholar 

Patel N, Barbieri A, Gibson J (2019) Neuroendocrine tumors of the gastrointestinal tract and pancreas. Surg Pathol Clin 12(4):1021–1044

PubMed  Google Scholar 

Galgano SJ, Wei B, Rose JB (2021) Pet imaging of neuroendocrine tumors. Radiol Clin 59(5):789–799

Google Scholar 

Sanli Y, Garg I, Kandathil A, Kendi T, Zanetti MJB, Kuyumcu S, Subramaniam RM (2018) Neuroendocrine tumor diagnosis and management: 68Ga-DOTATATE PET/CT. Am J Roentgenol 211(2):267–277

Google Scholar 

Cives M, Strosberg JR (2018) Gastroenteropancreatic neuroendocrine tumors. CA: Cancer J Clinic 68(6):471–87

Google Scholar 

Hennigs JK, Müller J, Adam M, Spin JM, Riedel E, Graefen M et al (2014) Loss of somatostatin receptor subtype 2 in prostate cancer is linked to an aggressive cancer phenotype, high tumor cell proliferation and predicts early metastatic and biochemical relapse. PLoS One 9(7):e100469

PubMed  PubMed Central  Google Scholar 

Lehman JM, Hoeksema MD, Staub J, Qian J, Harris B, Callison JC et al (2019) Somatostatin receptor 2 signaling promotes growth and tumor survival in small-cell lung cancer. Int J Cancer 144(5):1104–1114

CAS  PubMed  Google Scholar 

Froidevaux S, Eberle AN (2002) Somatostatin analogs and radiopeptides in cancer therapy. Pept Sci Orig Res Biomol 66(3):161–183

CAS  Google Scholar 

Cuccurullo V, Prisco RM, Di Stasio DG, Mansi L (2017) Nuclear medicine in patients with NET: radiolabeled somatostatin analogues and their brothers. Curr Radiopharmaceut 10(2):74–84

CAS  Google Scholar 

Rodrigues M, Winkler K-K, Svirydenka H, Nilica B, Uprimny C, Virgolini I (2021) Long-term survival and value of 18F-FDG PET/CT in patients with gastroenteropancreatic neuroendocrine tumors treated with second peptide receptor radionuclide therapy course with 177Lu-DOTATATE. Life 11(3):198

CAS  PubMed  PubMed Central  Google Scholar 

Skoura E, Michopoulou S, Mohmaduvesh M, Panagiotidis E, Al Harbi M, Toumpanakis C et al (2016) The impact of 68Ga-DOTATATE PET/CT imaging on management of patients with neuroendocrine tumors: experience from a national referral center in the United Kingdom. J Nucl Med 57(1):34–40

CAS  PubMed  Google Scholar 

Boutin NT, Schecter SB, Perez EF, Tchamitchian NS, Cerretani XR, Gainer VS et al (2022) The evolution of a large biobank at Mass General Brigham. J Personal Med 12(8):1323

Google Scholar 

Stensbøl AB, Krogh J, Holmager P, Klose M, Oturai P, Kjaer A et al (2021) Incidence, clinical presentation and trends in indication for diagnostic work-up of small intestinal and pancreatic neuroendocrine tumors. Diagnostics 11(11):2030

PubMed  PubMed Central  Google Scholar 

Metser U, Ezzat S, Singh S, Myrehaug S, Rahimi S, Gray D, Singnurkar A (2023) 68Ga-DOTATATE PET/CT in the initial diagnosis of patients with clinical, imaging, and/or biochemical suspicion of a neuroendocrine tumor. Clin Nucl Med 48(11):933–936

PubMed  Google Scholar 

Xu S, Pan Y, Zhou J, Ju H, Zhang Y (2022) Integrated PET/MRI with 68Ga-DOTATATE and 18F-FDG in pheochromocytomas and paragangliomas: an initial study. Clin Nucl Med 47(4):299–304

PubMed  Google Scholar 

Zheng GX, Terry JM, Belgrader P, Ryvkin P, Bent ZW, Wilson R et al (2017) Massively parallel digital transcriptional profiling of single cells. Nat Commun 8(1):14049

CAS  PubMed  PubMed Central  Google Scholar 

Lopez R, Regier J, Cole MB, Jordan MI, Yosef N (2018) Deep generative modeling for single-cell transcriptomics. Nat Methods 15(12):1053–1058

CAS  PubMed  PubMed Central  Google Scholar 

Muyas F, Sauer CM, Valle-Inclán JE, Li R, Rahbari R, Mitchell TJ et al (2024) De novo detection of somatic mutations in high-throughput single-cell profiling data sets. Nat Biotechnol 42(5):758–767

CAS  PubMed  Google Scholar 

Wolf FA, Angerer P, Theis FJ (2018) SCANPY: large-scale single-cell gene expression data analysis. Genome Biol 19:1–5

Google Scholar 

Subramanian A, Narayan R, Corsello SM, Peck DD, Natoli TE, Lu X et al (2017) A next generation connectivity map L1000 platform and the first 1,000,000 profiles. Cell 171(6):1437–52

CAS  PubMed  PubMed Central  Google Scholar 

Karczewski KJ, Francioli LC, Tiao G, Cummings BB, Alföldi J, Wang Q et al (2020) The mutational constraint spectrum quantified from variation in 141,456 humans. Nature 581(7809):434–443

CAS  PubMed  PubMed Central  Google Scholar 

Jia D, Augert A, Kim D-W, Eastwood E, Wu N, Ibrahim AH et al (2018) Crebbp loss drives small cell lung cancer and increases sensitivity to HDAC inhibition. Cancer Discov 8(11):1422–1437

CAS  PubMed  PubMed Central  Google Scholar 

van Riet J, van de Werken HJ, Cuppen E, Eskens FA, Tesselaar M, van Veenendaal LM et al (2021) The genomic landscape of 85 advanced neuroendocrine neoplasms reveals subtype-heterogeneity and potential therapeutic targets. Nat Commun 12(1):4612

PubMed  PubMed Central  Google Scholar 

Kumar M, Molkentine D, Molkentine J, Bridges K, Xie T, Yang L et al (2021) Inhibition of histone acetyltransferase function radiosensitizes CREBBP/EP300 mutants via repression of homologous recombination, potentially targeting a gain of function. Nat Commun 12(1):6340

CAS  PubMed  PubMed Central  Google Scholar 

Rahman I, Marwick J, Kirkham P (2004) Redox modulation of chromatin remodeling: impact on histone acetylation and deacetylation, NF-κB and pro-inflammatory gene expression. Biochem Pharmacol 68(6):1255–1267

CAS  PubMed  Google Scholar 

Yang M, Yi P, Jiang J, Zhao M, Wu H, Lu Q (2023) Dysregulated translational factors and epigenetic regulations orchestrate in B cells contributing to autoimmune diseases. Int Rev Immunol 42(1):1–25

PubMed  Google Scholar 

Chakraborty R, Ostriker AC, Xie Y, Dave JM, Gamez-Mendez A, Chatterjee P et al (2022) Histone acetyltransferases p300 and CBP coordinate distinct chromatin remodeling programs in vascular smooth muscle plasticity. Circulation 145(23):1720–1737

CAS  PubMed  PubMed Central  Google Scholar 

Klomp MJ, Dalm SU, van Koetsveld PM, Dogan F, de Jong M, Hofland LJ (2021) Comparing the effect of multiple histone deacetylase inhibitors on SSTR2 expression and [111In] In-DOTATATE uptake in NET cells. Cancers 13(19):4905

CAS  PubMed  PubMed Central  Google Scholar 

Guenter RE, Aweda T, Carmona Matos DM, Whitt J, Chang AW, Cheng EY et al (2019) Pulmonary carcinoid surface receptor modulation using histone deacetylase inhibitors. Cancers (Basel) 11(6):767

CAS  PubMed  Google Scholar 

Guenter R, Aweda T, Matos DMC, Jang S, Whitt J, Cheng Y-Q et al (2020) Overexpression of somatostatin receptor type 2 in neuroendocrine tumors for improved Ga68-DOTATATE imaging and treatment. Surgery 167(1):189–196

PubMed  Google Scholar 

Klomp MJ, van den Brink L, van Koetsveld PM, de Ridder CM, Stuurman DC, Löwik CW et al (2023) Applying HDACis to increase SSTR2 expression and radiolabeled DOTA-TATE uptake: from cells to mice. Life Sci 334:122173

CAS  PubMed  Google Scholar 

Refardt J, Klomp MJ, van Koetsveld PM, Dogan F, Konijnenberg M, Brabander T, Feelders RA, de Herder WW, Hofland LJ, Hofland J. Effect of epigenetic treatment on SST2 expression in neuroendocrine tumour patients. Clinical and Translational Medicine. 2022 Jul 22;12(7):e957.